Cita APA

Fujimura, M., Katsumata, N., Tsuda, H., Uchi, N., Miyazaki, S., Hidaka, T., . . . Saito, S. (2002). HER2 Is Frequently Over‐expressed in Ovarian Clear Cell Adenocarcinoma: Possible Novel Treatment Modality Using Recombinant Monoclonal Antibody against HER2, Trastuzumab. Jpn J Cancer Res.

Citación estilo Chicago

Fujimura, Masaki, Noriyuki Katsumata, Hiroshi Tsuda, Naoko Uchi, Satomi Miyazaki, Takao Hidaka, Masatoshi Sakai, and Shigeru Saito. "HER2 Is Frequently Over‐expressed in Ovarian Clear Cell Adenocarcinoma: Possible Novel Treatment Modality Using Recombinant Monoclonal Antibody against HER2, Trastuzumab." Jpn J Cancer Res 2002.

Cita MLA

Fujimura, Masaki, et al. "HER2 Is Frequently Over‐expressed in Ovarian Clear Cell Adenocarcinoma: Possible Novel Treatment Modality Using Recombinant Monoclonal Antibody against HER2, Trastuzumab." Jpn J Cancer Res 2002.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.